Ingredient

Linagliptin Micronized

Linagliptin is a glucose control ingredient used in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
106
Single ingredient
5
Combination
101
Prescription medication
106

MFDS ingredient code M268745

What does it do?

Linagliptin belongs to the DPP-4 inhibitor class of antidiabetic medications. This ingredient is used to promote insulin secretion and inhibit blood sugar increases to lower blood glucose levels.

Linagliptin contributes to blood sugar control by preventing the breakdown of incretin hormones in the body, which increases insulin secretion and helps reduce glucose production in the liver when blood sugar is high.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other DPP-4 inhibitors, Linagliptin is primarily metabolized in the liver and has low renal excretion, making it relatively safe for use in patients with impaired kidney function.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

106 total

View more

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.